Assessing the Benefit of Higher Biologically Effective Dose in Patients With Squamous Cell Carcinoma of the Lung Treated With Stereotactic Body Radiation Therapy

Authors

J S. Parzen, Beaumont Health Resident
M F. Almahariq, Beaumont Health
T J. Quinn, Beaumont Health
Z A. Siddiqui
A Thompson, Beaumont Health
T M. Guerrero, Beaumont Health
K C. Lee Jr, Beaumont Health
C W. Stevens, Beaumont Health
I S. Grills, Beaumont Health

Document Type

Conference Proceeding

Publication Date

11-1-2021

Publication Title

International Journal of Radiation Oncology Biology Physics

Volume

111

Issue

3S

First Page

E448

Last Page

E448

Recommended Citation

Parzen JS, Almahariq MF, Quinn TJ, Siddiqui ZA, Thompson A, Guerrero TM, Lee KC, Stevens CW, Grills IS. Assessing the Benefit of Higher Biologically Effective Dose in Patients With Squamous Cell Carcinoma of the Lung Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 2021 Nov 1;111(3):e448.

DOI

10.1016/j.ijrobp.2021.07.1264